| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ligase activity | 4.56e-05 | 174 | 74 | 6 | GO:0016874 | |
| GeneOntologyBiologicalProcess | biphenyl catabolic process | 2.35e-06 | 8 | 73 | 3 | GO:0070980 | |
| GeneOntologyBiologicalProcess | biphenyl metabolic process | 5.01e-06 | 10 | 73 | 3 | GO:0018879 | |
| GeneOntologyBiologicalProcess | benzene-containing compound metabolic process | 8.73e-06 | 37 | 73 | 4 | GO:0042537 | |
| GeneOntologyBiologicalProcess | organophosphate metabolic process | FCSK FASN CAD PDE4D PIK3C3 PLCH2 ACSM1 DOLK FLCN NR1H2 ABCD1 ACSS2 ABCC6 GFPT1 MMUT | 9.03e-06 | 1142 | 73 | 15 | GO:0019637 |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 9.15e-06 | 12 | 73 | 3 | GO:0052697 | |
| GeneOntologyBiologicalProcess | short-chain fatty acid metabolic process | 3.34e-05 | 18 | 73 | 3 | GO:0046459 | |
| GeneOntologyBiologicalProcess | acyl-CoA metabolic process | 4.24e-05 | 109 | 73 | 5 | GO:0006637 | |
| GeneOntologyBiologicalProcess | thioester metabolic process | 4.24e-05 | 109 | 73 | 5 | GO:0035383 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid metabolic process | FASN ACSM1 UGT2B7 FLCN NR1H2 ABCD1 HADH UGT2B28 ACSS2 UGT2B11 MMUT | 4.94e-05 | 731 | 73 | 11 | GO:0032787 |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 5.40e-05 | 21 | 73 | 3 | GO:0052695 | |
| GeneOntologyBiologicalProcess | carboxylic acid metabolic process | FASN CAD ACSM1 UGT2B7 FLCN NR1H2 ABCD1 HADH UGT2B28 ACSS2 UGT2B11 GFPT1 MMUT | 6.19e-05 | 1035 | 73 | 13 | GO:0019752 |
| GeneOntologyBiologicalProcess | nucleobase-containing small molecule metabolic process | 7.60e-05 | 767 | 73 | 11 | GO:0055086 | |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | FASN CAD ACSM1 UGT2B7 FLCN NR1H2 ABCD1 HADH UGT2B28 ACSS2 UGT2B11 GFPT1 MMUT | 7.74e-05 | 1058 | 73 | 13 | GO:0043436 |
| GeneOntologyBiologicalProcess | organic acid metabolic process | FASN CAD ACSM1 UGT2B7 FLCN NR1H2 ABCD1 HADH UGT2B28 ACSS2 UGT2B11 GFPT1 MMUT | 8.20e-05 | 1064 | 73 | 13 | GO:0006082 |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 1.04e-04 | 26 | 73 | 3 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 1.04e-04 | 26 | 73 | 3 | GO:0006063 | |
| GeneOntologyBiologicalProcess | ribonucleotide metabolic process | 1.07e-04 | 533 | 73 | 9 | GO:0009259 | |
| GeneOntologyBiologicalProcess | ribose phosphate metabolic process | 1.18e-04 | 540 | 73 | 9 | GO:0019693 | |
| GeneOntologyBiologicalProcess | propionate metabolic process | 1.23e-04 | 5 | 73 | 2 | GO:0019541 | |
| GeneOntologyBiologicalProcess | positive regulation of macrophage fusion | 1.23e-04 | 5 | 73 | 2 | GO:0034241 | |
| GeneOntologyBiologicalProcess | nucleotide metabolic process | 1.42e-04 | 684 | 73 | 10 | GO:0009117 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 1.44e-04 | 141 | 73 | 5 | GO:0006805 | |
| GeneOntologyBiologicalProcess | nucleoside bisphosphate metabolic process | 1.49e-04 | 142 | 73 | 5 | GO:0033865 | |
| GeneOntologyBiologicalProcess | ribonucleoside bisphosphate metabolic process | 1.49e-04 | 142 | 73 | 5 | GO:0033875 | |
| GeneOntologyBiologicalProcess | purine nucleoside bisphosphate metabolic process | 1.49e-04 | 142 | 73 | 5 | GO:0034032 | |
| GeneOntologyBiologicalProcess | nucleoside phosphate metabolic process | 1.54e-04 | 691 | 73 | 10 | GO:0006753 | |
| GeneOntologyBiologicalProcess | regulation of macrophage fusion | 1.84e-04 | 6 | 73 | 2 | GO:0034239 | |
| GeneOntologyBiologicalProcess | xenobiotic catabolic process | 3.03e-04 | 37 | 73 | 3 | GO:0042178 | |
| GeneOntologyBiologicalProcess | androgen metabolic process | 3.28e-04 | 38 | 73 | 3 | GO:0008209 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative metabolic process | FCSK FASN CAD PDE4D ACSM1 DOLK FLCN ABCD1 ACSS2 TET3 ABCC6 GFPT1 MMUT | 3.32e-04 | 1226 | 73 | 13 | GO:1901135 |
| GeneOntologyBiologicalProcess | macrophage fusion | 3.41e-04 | 8 | 73 | 2 | GO:0034238 | |
| GeneOntologyBiologicalProcess | positive regulation of apoptotic cell clearance | 3.41e-04 | 8 | 73 | 2 | GO:2000427 | |
| GeneOntologyBiologicalProcess | purine ribonucleotide metabolic process | 4.46e-04 | 512 | 73 | 8 | GO:0009150 | |
| GeneOntologyBiologicalProcess | response to xenobiotic stimulus | 5.26e-04 | 525 | 73 | 8 | GO:0009410 | |
| GeneOntologyBiologicalProcess | regulation of apoptotic cell clearance | 5.46e-04 | 10 | 73 | 2 | GO:2000425 | |
| GeneOntologyBiologicalProcess | fatty acid biosynthetic process | 5.83e-04 | 191 | 73 | 5 | GO:0006633 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 8.30e-04 | 52 | 73 | 3 | GO:0008210 | |
| GeneOntologyBiologicalProcess | aminoacyl-tRNA metabolism involved in translational fidelity | 9.40e-04 | 13 | 73 | 2 | GO:0106074 | |
| GeneOntologyCellularComponent | nuclear outer membrane | 1.20e-05 | 40 | 74 | 4 | GO:0005640 | |
| GeneOntologyCellularComponent | symbiont cell surface | 3.41e-04 | 8 | 74 | 2 | GO:0106139 | |
| GeneOntologyCellularComponent | other organism part | 4.38e-04 | 9 | 74 | 2 | GO:0044217 | |
| Domain | UDPGT | 6.95e-05 | 21 | 72 | 3 | PF00201 | |
| Domain | UDPGT | 6.95e-05 | 21 | 72 | 3 | PS00375 | |
| Domain | UDP_glucos_trans | 6.95e-05 | 21 | 72 | 3 | IPR002213 | |
| Domain | Anaphylatoxin_comp_syst | 1.45e-04 | 5 | 72 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 1.45e-04 | 5 | 72 | 2 | IPR001840 | |
| Domain | ABC_TM1F | 1.68e-04 | 28 | 72 | 3 | PS50929 | |
| Domain | ABC1_TM_dom | 1.68e-04 | 28 | 72 | 3 | IPR011527 | |
| Domain | ANATO | 3.04e-04 | 7 | 72 | 2 | SM00104 | |
| Domain | ANATO | 3.04e-04 | 7 | 72 | 2 | PF01821 | |
| Domain | ANAPHYLATOXIN_2 | 3.04e-04 | 7 | 72 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 3.04e-04 | 7 | 72 | 2 | PS01177 | |
| Domain | Anaphylatoxin/fibulin | 3.04e-04 | 7 | 72 | 2 | IPR000020 | |
| Domain | Thiol-ester_cl | 4.04e-04 | 8 | 72 | 2 | PF10569 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 4.04e-04 | 8 | 72 | 2 | IPR019565 | |
| Domain | MacrogloblnA2_CS | 4.04e-04 | 8 | 72 | 2 | IPR019742 | |
| Domain | ABC_transporter_CS | 5.66e-04 | 42 | 72 | 3 | IPR017871 | |
| Domain | A2M_N | 6.46e-04 | 10 | 72 | 2 | PF01835 | |
| Domain | A2M_N | 6.46e-04 | 10 | 72 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 6.46e-04 | 10 | 72 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 6.46e-04 | 10 | 72 | 2 | PS00477 | |
| Domain | A2M | 6.46e-04 | 10 | 72 | 2 | PF00207 | |
| Domain | A2M_N_2 | 6.46e-04 | 10 | 72 | 2 | IPR011625 | |
| Domain | A2M_comp | 6.46e-04 | 10 | 72 | 2 | IPR011626 | |
| Domain | A2M_N_2 | 6.46e-04 | 10 | 72 | 2 | PF07703 | |
| Domain | A2M_recep | 6.46e-04 | 10 | 72 | 2 | PF07677 | |
| Domain | A2M_comp | 6.46e-04 | 10 | 72 | 2 | PF07678 | |
| Domain | Macroglobln_a2 | 6.46e-04 | 10 | 72 | 2 | IPR001599 | |
| Domain | ABC_tran | 8.39e-04 | 48 | 72 | 3 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 8.39e-04 | 48 | 72 | 3 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 8.91e-04 | 49 | 72 | 3 | PS00211 | |
| Domain | ABC_transporter-like | 9.45e-04 | 50 | 72 | 3 | IPR003439 | |
| Domain | EGF_extracell | 1.61e-03 | 60 | 72 | 3 | IPR013111 | |
| Domain | EGF_2 | 1.61e-03 | 60 | 72 | 3 | PF07974 | |
| Domain | C345C | 1.92e-03 | 17 | 72 | 2 | SM00643 | |
| Domain | AMP-bd_C | 1.92e-03 | 17 | 72 | 2 | IPR025110 | |
| Domain | AMP-binding_C | 1.92e-03 | 17 | 72 | 2 | PF13193 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 2.15e-03 | 18 | 72 | 2 | IPR008930 | |
| Domain | NTR | 2.40e-03 | 19 | 72 | 2 | PF01759 | |
| Domain | Netrin_module_non-TIMP | 2.40e-03 | 19 | 72 | 2 | IPR018933 | |
| Domain | NTR | 3.52e-03 | 23 | 72 | 2 | PS50189 | |
| Domain | Netrin_domain | 3.52e-03 | 23 | 72 | 2 | IPR001134 | |
| Domain | Metal_Hydrolase | 3.83e-03 | 24 | 72 | 2 | IPR032466 | |
| Domain | ABC_membrane | 3.83e-03 | 24 | 72 | 2 | PF00664 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 8.99e-05 | 107 | 60 | 5 | MM14595 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 9.81e-05 | 109 | 60 | 5 | M18788 | |
| Pathway | WP_FATTY_ACID_BIOSYNTHESIS | 1.07e-04 | 22 | 60 | 3 | M39440 | |
| Pathway | WP_FATTY_ACID_BIOSYNTHESIS | 1.22e-04 | 23 | 60 | 3 | MM15885 | |
| Pathway | REACTOME_PREDNISONE_ADME | 1.22e-04 | 23 | 60 | 3 | MM16639 | |
| Pathway | REACTOME_GLUCURONIDATION | 1.39e-04 | 24 | 60 | 3 | MM14599 | |
| Pathway | REACTOME_GLUCURONIDATION | 1.58e-04 | 25 | 60 | 3 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 1.58e-04 | 25 | 60 | 3 | MM15820 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 1.58e-04 | 25 | 60 | 3 | M605 | |
| Pathway | WP_GLUCURONIDATION | 1.78e-04 | 26 | 60 | 3 | M39404 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 2.23e-04 | 28 | 60 | 3 | M19580 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 3.27e-04 | 219 | 60 | 6 | MM14838 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 3.35e-04 | 220 | 60 | 6 | M10320 | |
| Pathway | REACTOME_ACTIVATION_OF_C3_AND_C5 | 3.69e-04 | 7 | 60 | 2 | MM14685 | |
| Pathway | REACTOME_ACTIVATION_OF_C3_AND_C5 | 4.91e-04 | 8 | 60 | 2 | M27031 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CLASSICAL_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION | 4.91e-04 | 8 | 60 | 2 | M47872 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 6.01e-04 | 39 | 60 | 3 | MM15695 | |
| Pathway | WP_AMINO_ACID_METABOLISM | 6.01e-04 | 91 | 60 | 4 | M39570 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_LIPOGENESIS | 6.29e-04 | 9 | 60 | 2 | M29789 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 6.96e-04 | 41 | 60 | 3 | M7399 | |
| Pathway | WP_AMINO_ACID_METABOLISM | 7.95e-04 | 98 | 60 | 4 | MM15942 | |
| Pathway | REACTOME_ASPIRIN_ADME | 8.57e-04 | 44 | 60 | 3 | M45014 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 8.57e-04 | 44 | 60 | 3 | M11911 | |
| Pathway | REACTOME_ASPIRIN_ADME | 9.16e-04 | 45 | 60 | 3 | MM15694 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 9.56e-04 | 11 | 60 | 2 | MM1430 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION | 9.56e-04 | 11 | 60 | 2 | M47874 | |
| Pathway | WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES | 1.12e-03 | 381 | 60 | 7 | M48063 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 1.14e-03 | 12 | 60 | 2 | MM1368 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 1.32e-03 | 51 | 60 | 3 | M17726 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 1.35e-03 | 13 | 60 | 2 | M4732 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 1.40e-03 | 52 | 60 | 3 | M14171 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 1.64e-03 | 55 | 60 | 3 | M14933 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSYLATION_PRECURSOR_BIOSYNTHESIS | 1.81e-03 | 15 | 60 | 2 | M27468 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 1.81e-03 | 15 | 60 | 2 | M7146 | |
| Pathway | WP_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY | 2.33e-03 | 17 | 60 | 2 | MM15944 | |
| Pathway | BIOCARTA_COMP_PATHWAY | 2.33e-03 | 17 | 60 | 2 | MM1369 | |
| Pathway | KEGG_RETINOL_METABOLISM | 2.54e-03 | 64 | 60 | 3 | M9488 | |
| Pathway | REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS | 2.54e-03 | 64 | 60 | 3 | M892 | |
| Pathway | BIOCARTA_COMP_PATHWAY | 3.22e-03 | 20 | 60 | 2 | M917 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 3.28e-03 | 70 | 60 | 3 | M16794 | |
| Pubmed | 3.22e-07 | 7 | 74 | 3 | 26074487 | ||
| Pubmed | 5.14e-07 | 8 | 74 | 3 | 32093886 | ||
| Pubmed | 6.67e-07 | 144 | 74 | 6 | 35681168 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | AARS1 FASN FAM234A PA2G4 ADAM9 TOM1 GEMIN4 RANBP6 ABCD1 PJA1 VARS1 GFPT1 | 6.82e-07 | 942 | 74 | 12 | 31073040 |
| Pubmed | 1.10e-06 | 496 | 74 | 9 | 31343991 | ||
| Pubmed | Mapping of the L-methylmalonyl-CoA mutase gene to mouse chromosome 17. | 2.60e-06 | 13 | 74 | 3 | 1970332 | |
| Pubmed | 4.26e-06 | 437 | 74 | 8 | 20562859 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 4.47e-06 | 2 | 74 | 2 | 16565498 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 15998580 | ||
| Pubmed | Structural polymorphism of murine C4 and its linkage to H-2. | 4.47e-06 | 2 | 74 | 2 | 7373044 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 19062096 | ||
| Pubmed | The chemical structure of the C4d fragment of the human complement component C4. | 4.47e-06 | 2 | 74 | 2 | 3696167 | |
| Pubmed | Restriction fragment length polymorphism of the murine C4 and Slp genes: two C4 groups. | 4.47e-06 | 2 | 74 | 2 | 1357031 | |
| Pubmed | Structural comparison of human C4A3 and C4B1 after proteolytic activation by C1s. | 4.47e-06 | 2 | 74 | 2 | 16098595 | |
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 4.47e-06 | 2 | 74 | 2 | 19933335 | |
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 4.47e-06 | 2 | 74 | 2 | 2459207 | |
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 4.47e-06 | 2 | 74 | 2 | 17645767 | |
| Pubmed | Increased frequency of C4B*Q0 alleles in patients with Henoch-Schönlein purpura. | 4.47e-06 | 2 | 74 | 2 | 15787745 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 12207352 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 30026462 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 6559257 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 4.47e-06 | 2 | 74 | 2 | 27758680 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 22387014 | ||
| Pubmed | Complement C4 Is Reduced in iPSC-Derived Astrocytes of Autism Spectrum Disorder Subjects. | 4.47e-06 | 2 | 74 | 2 | 34299197 | |
| Pubmed | Assessment of complement C4 gene copy number using the paralog ratio test. | 4.47e-06 | 2 | 74 | 2 | 20506482 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 12480675 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 26800705 | ||
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 4.47e-06 | 2 | 74 | 2 | 23749435 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 23918728 | ||
| Pubmed | Expression of the human ABCC6 gene is induced by retinoids through the retinoid X receptor. | 4.47e-06 | 2 | 74 | 2 | 17045963 | |
| Pubmed | Murine complement C4 is not required for experimental autoimmune encephalomyelitis. | 4.47e-06 | 2 | 74 | 2 | 15390104 | |
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 4.47e-06 | 2 | 74 | 2 | 3037333 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 11726230 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 4216347 | ||
| Pubmed | Importance of the alpha 3-fragment of complement C4 for the binding with C4b-binding protein. | 4.47e-06 | 2 | 74 | 2 | 1699796 | |
| Pubmed | Sequence determination of the thiolester site of the fourth component of human complement. | 4.47e-06 | 2 | 74 | 2 | 6950384 | |
| Pubmed | Molecular cloning and characterization of complementary and genomic DNA clones for mouse C4 and Slp. | 4.47e-06 | 2 | 74 | 2 | 2997024 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 8660986 | ||
| Pubmed | Constitutive expression of Slp genes in mouse strain B10.WR directed by C4 regulatory sequences. | 4.47e-06 | 2 | 74 | 2 | 3624865 | |
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 4.47e-06 | 2 | 74 | 2 | 8428773 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 21857912 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 24638111 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 6208559 | ||
| Pubmed | The role of the histocompatibility-2-linked Ss-Slp region in the control of mouse complement. | 4.47e-06 | 2 | 74 | 2 | 4514997 | |
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 4.47e-06 | 2 | 74 | 2 | 21345967 | |
| Pubmed | The inheritance of susceptibility to the Gross leukemia virus in mice. | 4.47e-06 | 2 | 74 | 2 | 5919331 | |
| Pubmed | An ancient provirus has imposed androgen regulation on the adjacent mouse sex-limited protein gene. | 4.47e-06 | 2 | 74 | 2 | 3167981 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 7545960 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 30041577 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 2572548 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 2302180 | ||
| Pubmed | Complete cDNA sequence of the fourth component of murine complement. | 4.47e-06 | 2 | 74 | 2 | 3862104 | |
| Pubmed | The BS variant of C4 protects against age-related loss of white matter microstructural integrity. | 4.47e-06 | 2 | 74 | 2 | 34358307 | |
| Pubmed | Acute renal allograft rejection: diagnostic significance of focal peritubular capillary C4d. | 4.47e-06 | 2 | 74 | 2 | 18360261 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 22151770 | ||
| Pubmed | C4d-positive chronic rejection: a frequent entity with a poor outcome. | 4.47e-06 | 2 | 74 | 2 | 18091514 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 29080553 | ||
| Pubmed | Schizophrenia risk from complex variation of complement component 4. | 4.47e-06 | 2 | 74 | 2 | 26814963 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 6589636 | ||
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 4.47e-06 | 2 | 74 | 2 | 25339671 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 17728371 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 6149580 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 6149581 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 12115608 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 3542363 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 2387317 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 8132550 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 2395880 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 21679149 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 26814708 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 6192448 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 6167582 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 16908004 | ||
| Pubmed | Slp is an essential component of an EDTA-resistant activation pathway of mouse complement. | 4.47e-06 | 2 | 74 | 2 | 1438267 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 7365238 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 19150565 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 7391573 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 17506029 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 17971360 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 23715124 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 3464002 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 2993295 | ||
| Pubmed | Clinical features of patients with homozygous complement C4A or C4B deficiency. | 4.47e-06 | 2 | 74 | 2 | 29928053 | |
| Pubmed | Analysis of C4 and the C4 binding protein in the MRL/lpr mouse. | 4.47e-06 | 2 | 74 | 2 | 17971229 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 6881182 | ||
| Pubmed | Identification of the site of sulfation of the fourth component of human complement. | 4.47e-06 | 2 | 74 | 2 | 3944109 | |
| Pubmed | Partial C4 deficiency in juvenile idiopathic arthritis patients. | 4.47e-06 | 2 | 74 | 2 | 17921792 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 21880985 | ||
| Pubmed | Amino acid sequence around the thiol and reactive acyl groups of human complement component C4. | 4.47e-06 | 2 | 74 | 2 | 6978711 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 35898513 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 33353966 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 3008092 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 28873507 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 6609966 | ||
| Pubmed | Heterogeneity and linkage of equine C4 and steroid 21-hydroxylase genes. | 4.47e-06 | 2 | 74 | 2 | 2900855 | |
| Pubmed | Inhibitors of VPS34 and fatty-acid metabolism suppress SARS-CoV-2 replication. | 4.47e-06 | 2 | 74 | 2 | 34320401 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 276882 | ||
| Pubmed | Amino acid sequence of a polymorphic segment from fragment C4d of human complement component C4. | 4.47e-06 | 2 | 74 | 2 | 6832377 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 3794341 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p21 | 1.66e-04 | 503 | 74 | 6 | chr6p21 | |
| Cytoband | 6p21.3 | 7.33e-04 | 250 | 74 | 4 | 6p21.3 | |
| Cytoband | 4q13.2 | 1.16e-03 | 31 | 74 | 2 | 4q13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q13 | 2.13e-03 | 157 | 74 | 3 | chr4q13 | |
| GeneFamily | UDP glucuronosyltransferases | 7.26e-05 | 32 | 46 | 3 | 363 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 2.25e-04 | 9 | 46 | 2 | 1234 | |
| GeneFamily | Acyl-CoA synthetase family | 1.98e-03 | 26 | 46 | 2 | 40 | |
| GeneFamily | Complement system|Sushi domain containing | 3.78e-03 | 36 | 46 | 2 | 492 | |
| GeneFamily | Glycosyltransferase family 6|Blood group antigens | 3.99e-03 | 37 | 46 | 2 | 454 | |
| Coexpression | YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN | 1.43e-05 | 17 | 74 | 3 | M9914 | |
| Coexpression | GSE19888_ADENOSINE_A3R_ACT_VS_A3R_ACT_WITH_A3R_INH_PRETREATMENT_IN_MAST_CELL_UP | 1.97e-05 | 196 | 74 | 6 | M7316 | |
| Coexpression | GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_DN | 2.02e-05 | 197 | 74 | 6 | M3438 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Papillary_Renal_Cell_Carcinoma|TCGA-Kidney / Sample_Type by Project: Shred V9 | 6.54e-07 | 185 | 74 | 6 | 46f4f6f20b1e152922f6f2ba1244c56e48a49b79 | |
| Drug | 2-O-Methylfucose | 5.34e-06 | 11 | 74 | 3 | CID000169586 | |
| Drug | AC1Q68ZE | 5.91e-06 | 79 | 74 | 5 | CID000000265 | |
| Drug | testosterone glucuronide | 9.50e-06 | 41 | 74 | 4 | CID000108192 | |
| Drug | 2-hydroxyestriol | 1.04e-05 | 2 | 74 | 2 | ctd:C008012 | |
| Drug | phenobarbital | 2.20e-05 | 360 | 74 | 8 | CID000004763 | |
| Drug | AC1NQGK1 | 2.47e-05 | 52 | 74 | 4 | CID005195977 | |
| Drug | C1 11-32 | 2.60e-05 | 18 | 74 | 3 | CID000443077 | |
| Drug | C11131 | 2.60e-05 | 18 | 74 | 3 | CID000443076 | |
| Drug | T4-G | 3.08e-05 | 19 | 74 | 3 | CID000152424 | |
| Drug | R-Q2 | 3.12e-05 | 3 | 74 | 2 | CID000095714 | |
| Drug | 2-aminothiophenol | 3.12e-05 | 3 | 74 | 2 | ctd:C005464 | |
| Drug | dehydroepiandrosterone sulfate | 3.28e-05 | 277 | 74 | 7 | CID000005244 | |
| Drug | acetaminophen glucuronide | 4.09e-05 | 59 | 74 | 4 | CID000083944 | |
| Drug | SN-38G | 4.09e-05 | 59 | 74 | 4 | CID000443154 | |
| Drug | estriol-16-glucuronide | 4.20e-05 | 21 | 74 | 3 | CID000122281 | |
| Drug | HMDS | 4.20e-05 | 21 | 74 | 3 | CID000013838 | |
| Drug | estradiol-3-glucuronide | 5.57e-05 | 23 | 74 | 3 | CID000066651 | |
| Drug | dimethyl itaconate | 6.23e-05 | 4 | 74 | 2 | CID000069240 | |
| Drug | oltipraz | 8.46e-05 | 137 | 74 | 5 | CID000047318 | |
| Drug | L-idaro-1,4-lactone | 1.02e-04 | 28 | 74 | 3 | CID000078997 | |
| Drug | GDP-Ara | 1.04e-04 | 5 | 74 | 2 | CID003036025 | |
| Drug | methoxyamine hydrochloride | 1.04e-04 | 5 | 74 | 2 | CID000011639 | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 1.63e-04 | 8 | 72 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 2.09e-04 | 9 | 72 | 2 | C3502809 | |
| Disease | plasma clozapine-to-N-desmethylclozapine ratio measurement | 2.09e-04 | 9 | 72 | 2 | EFO_0600040 | |
| Disease | Congenital Disorders of Glycosylation | 2.61e-04 | 10 | 72 | 2 | C0282577 | |
| Disease | X-19141 measurement | 4.50e-04 | 13 | 72 | 2 | EFO_0800799 | |
| Disease | renal cell carcinoma (is_implicated_in) | 6.50e-04 | 69 | 72 | 3 | DOID:4450 (is_implicated_in) | |
| Disease | hair colour measurement | 7.54e-04 | 615 | 72 | 7 | EFO_0007822 | |
| Disease | Intellectual Disability | 7.85e-04 | 447 | 72 | 6 | C3714756 | |
| Disease | phosphatidylcholine 36:4 measurement | 8.76e-04 | 18 | 72 | 2 | EFO_0010382 | |
| Disease | rheumatoid arthritis | 9.32e-04 | 462 | 72 | 6 | EFO_0000685 | |
| Disease | lung carcinoma | 1.16e-03 | 482 | 72 | 6 | EFO_0001071 | |
| Disease | X-24947 measurement | 1.31e-03 | 22 | 72 | 2 | EFO_0800910 | |
| Disease | sphingomyelin 24:1 measurement | 1.44e-03 | 23 | 72 | 2 | EFO_0010398 | |
| Disease | Obesity | 1.61e-03 | 205 | 72 | 4 | C0028754 | |
| Disease | sunburn | 1.69e-03 | 96 | 72 | 3 | EFO_0003958 | |
| Disease | mammographic density percentage | 2.28e-03 | 29 | 72 | 2 | EFO_0006502 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LANVSTHIVAFDAVL | 471 | Q9H0X4 | |
| DETVALTAFVTIALH | 1136 | P0C0L5 | |
| FDAVVASEVVEHVID | 216 | Q9NZJ6 | |
| VDSSEVVIHSADAFA | 221 | Q7L8W6 | |
| VASQILVTIAASDHA | 1846 | Q8WXG9 | |
| FVGSEAVDVIFSHLI | 66 | Q96QD5 | |
| SALVEHEAVAEAAVV | 586 | Q9NR19 | |
| VVTDAFLAVAGHIFS | 101 | Q9UMX3 | |
| TISVAVGLSVDFAVH | 1041 | Q96F81 | |
| EAIVAALLTRTFTDH | 451 | Q96GQ7 | |
| HVSAVAAAAIFVIII | 311 | Q29983 | |
| SLTEDVVAFAASVAH | 196 | P33897 | |
| GFIANVAHTFVVDVA | 116 | Q9UQ80 | |
| LAEAAVVFAVVLSIH | 21 | Q9UPQ8 | |
| LSSEFAVIVEVHAAA | 431 | Q8NFG4 | |
| LLLAAVAEVEDVASH | 536 | Q6ZRQ5 | |
| AASVVHSTDLVVEAI | 106 | Q16836 | |
| ESEFVHVVAISFTAL | 1036 | O43861 | |
| TSALTHDAILVIAEA | 306 | P42263 | |
| EALVNIIAVHAEVFT | 801 | Q96KP1 | |
| AHTVVADALAKAVAE | 356 | Q86V87 | |
| EILAAIFASAIHDVD | 491 | Q08499 | |
| VTEELAAATAQVSHL | 641 | Q5T1M5 | |
| VALALEVASIDHISE | 66 | O14764 | |
| LSVEVTLHVAANFSV | 126 | O75144 | |
| FHDSVTEIAIEIAFK | 921 | Q9ULD6 | |
| VFFSVETAERLLATH | 226 | Q8N0W3 | |
| DETSTIALFKAHEVA | 176 | Q9H7D0 | |
| ITVETFASIVAHELG | 336 | Q13443 | |
| TVAHIVVEAASLAAD | 116 | Q66K89 | |
| VVEAASLAADISHAS | 121 | Q66K89 | |
| LESFIHVAVSDSATL | 796 | Q5TBA9 | |
| EVACVAVHDESAFVV | 51 | Q9UHL9 | |
| FDDIVHSFVSLTAIQ | 546 | P49327 | |
| AFTASVQHVEAELSA | 51 | Q9P086 | |
| DETVALTAFVTIALH | 1136 | P0C0L4 | |
| ACTDTFLVVIVDAIH | 216 | Q8NGW6 | |
| VDAIHAAEIVASFLV | 226 | Q8NGW6 | |
| LSAAVTEAFVRLHEE | 451 | P26640 | |
| FESVLVDAFSHVARE | 81 | Q9NQG5 | |
| VVALVAVAEHSGEFE | 36 | Q17R31 | |
| ASAVIEHTNRVIFLE | 281 | Q06210 | |
| VALVVFAVHTLVAEN | 546 | O95255 | |
| ELSVDEAALHAAVIA | 206 | Q13576 | |
| RFAHFTELAIISVQE | 266 | P55055 | |
| SLIDESVHALFAAVV | 861 | Q8NEB9 | |
| VATAVAVATDHVAFL | 311 | Q9BR26 | |
| AVATDHVAFLLAQAT | 316 | Q9BR26 | |
| VQSHAASALIIFIED | 466 | O60518 | |
| IFIAHRLSTVVDADE | 661 | O75027 | |
| SALVEHPAVAESAVV | 486 | Q08AH1 | |
| ALVHAASAFEVDVVV | 241 | Q92989 | |
| NVESSAELVFVSHVI | 411 | Q9BXT8 | |
| LQISDAVHFFTEELA | 151 | Q86WT6 | |
| TDTLFDVNAIVAHVL | 116 | Q9P2K2 | |
| VRSFSLEAAEVLVEH | 766 | Q96KV7 | |
| AEVNLAEHSTVITFL | 2391 | Q96RL7 | |
| EVFDSAILSAIEHKA | 196 | Q96L33 | |
| SSHAGAFVIVTEEAI | 731 | P49588 | |
| ELVVVVAATLASHFG | 336 | P50443 | |
| HVLVASQDFVESVLV | 86 | O60784 | |
| EEASIFVHVAVSDIS | 871 | O75038 | |
| VIAFVFEVSTSEHGA | 411 | Q99594 | |
| VLTHFAVAGETILVD | 986 | Q92752 | |
| VAIHATLESATALAV | 1461 | Q6N022 | |
| DAHDLVAFSAVAEAV | 196 | O43151 | |
| HEVTVLASSASILFD | 51 | O75310 | |
| IVEAVDIASAAKHFD | 176 | O15213 | |
| ASDGVVAAIAISEHV | 1141 | P27708 | |
| VSDVVDSDITVHNFV | 41 | P17010 | |
| HEVTVLASSASILFD | 51 | Q9BY64 | |
| HEVTVLASSASILFD | 51 | P16662 | |
| LEAAAHSAVTAVADA | 1291 | Q9H4Z2 | |
| ALAHLESLAVDVEVA | 551 | Q8NG27 | |
| EAAAVALSSLIHALD | 371 | P13010 | |
| EHVTVDTSAEDVAFF | 146 | P57678 | |
| AVDADVHAVGISTLA | 661 | P22033 |